ELK Biotechnology
FGF10 Rabbit Polyclonal Antibody - ES9144
FGF10 Rabbit Polyclonal Antibody - ES9144
Couldn't load pickup availability
FGF10 Rabbit Polyclonal Antibody
Sizes: 50μL, 100μL
Catalogue Numbers: ES9144-50, ES9144-100
Lead times: 1-2 weeks, if manufacturer has product in stock
Manufacturer/Ship Location: China
Background: The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This protein exhibits mitogenic activity for keratinizing epidermal cells, but essentially no activity for fibroblasts, which is similar to the biological activity of FGF7. Studies of the mouse homolog of suggested that this gene is required for embryonic epidermal morphogenesis including brain development, lung morphogenesis, and initiation of lim bud formation. This gene is also implicated to be a primary factor in the process of wound healing. [provided by RefSeq, Jul 2008],
Reactivity: Human, Mouse, Rat
Host: Rabbit
Applications: WB, ELISA
Clonality: Polyclonal
Immunogen: Synthesized peptide derived from human protein. at AA range: 120-200
Isotype: IgG
Target: FGF10
Specificity: FGF10 Polyclonal Antibody detects endogenous levels of protein.
Dilution: WB 1:500-2000 ELISA 1:5000-20000
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/ml,
Formlation: Liquid in PBS containing 50% glycerol, and 0.02% sodium azide.
Expression: Bladder, Brain, Lung,
Observed Band (KD): 22kD
Fields: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways in cancer, Chemical carcinogenesis - receptor activation, Melanoma, Breast cancer, Gastric cancer
Function: Disease: Defects in FGF10 are a cause of lacrimo-auriculo-dento-digital syndrome (LADDS) [MIM: 149730], also known as Levy-Hollister syndrome. LADDS is a form of ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. LADDS is an autosomal dominant syndrome characterized by aplastic/hypoplastic lacrimal and salivary glands and ducts, cup-shaped ears, hearing loss, hypodontia and enamel hypoplasia, and distal limb segments anomalies. In addition to these cardinal features, facial dysmorphism, malformations of the kidney and respiratory system and abnormal genitalia have been reported. Craniosynostosis and severe syndactyly are not observed
Disease: Defects in FGF10 are the cause of autosomal dominant aplasia of lacrimal and salivary glands (ALSG) [MIM: 180920]. ALSG has variable expressivity, and affected individuals may have
Subcellular Location: Secreted
Storage and Stability: -20°C/1 year
Gene Name: FGF10
Protein Name: Fibroblast growth factor 10 (FGF-10) (Keratinocyte growth factor 2)
Mouse SwissProt Number: O35565
Rat SwissProt Number: P70492
Research Use Only
